Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Human Tetanus Immunoglobulin

Approval Number

国药准字S20083045

Company诺一生物医药股份有限公司

Registration Date

February 6, 2024

Drug Information

Generic Name

破伤风人免疫球蛋白

Dosage Form

注射剂

Strength

250IU/瓶

Drug Type

生物制品

Registration Date

February 6, 2024

Company Information

Applicant Company

Company Name诺一生物医药股份有限公司

Company Address

上海市闵行区昆阳路1508号第2幢11层1108室

Manufacturing Company

Company Name诺一生物医药股份有限公司

Company Address

中国（上海）自由贸易试验区南洋泾路518号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy